Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Change in Taxes (2016 - 2025)

Theravance Biopharma (TBPH) has disclosed Change in Taxes for 7 consecutive years, with -$22.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Taxes changed N/A to -$22.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$22.7 million, a N/A change, with the full-year FY2020 number at $258000.0, down 93.03% from a year prior.
  • Change in Taxes was -$22.6 million for Q3 2025 at Theravance Biopharma, down from $295000.0 in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of -$22.6 million in Q3 2025 to a low of -$22.6 million in Q3 2025.